The global medical tubing market size is expected to reach USD 25.5 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. The prevalence of respiratory diseases such as asthma, lung cancer, and pulmonary fibrosis worldwide is anticipated to fuel the global demand for medical tubing, as it is essential component of respiratory devices such as ventilators and nebulizers.
Growing awareness among the masses about hospital-acquired diseases and surging concerns about the spread of such infections are projected to drive demand for disposable medical devices. According to the World Health Organization (WHO), the incidences of ICU-acquired infections are 2 to 3 times higher in low- and middle-income countries than in high-income countries, while device-associated infections are approximately 13 times higher in these countries than in the U.S.
Governments, predominantly in emerging economies, are investing in their medical infrastructure and insurance to help the masses afford proper healthcare when required to prevent the occurrence of chronic diseases in them. Additionally, as these countries are growing economically, the standard of living of their population is also improving, which makes it possible for them to have access to advanced healthcare. These factors are anticipated to fuel the growth of medical tubing product demand over the forecast period.
According to a report by the Australian Government Department of Health, approximately 47% of the Australian population, or 11.6 million people, will have one or more of the 10 selected chronic conditions such as back pain, cancer, chronic obstructive pulmonary diseases, mental health conditions, diabetes, asthma, and arthritis by 2020–2021. Thus, the occurrence of life-threatening diseases and chronic diseases is anticipated to be one of the major factors boosting market growth.
Medical tubing manufacturers are seeking collaborations, mergers, and acquisitions to develop advanced and innovative solutions. In addition, manufacturers are also adopting several strategies, like new product development, and geographical expansion, to enhance their market penetration and cater to end-use industries. For instance, Nordson Corporation acquired NDC Technologies. The aim behind the acquisition is to expand the former’s test and inspection platform into new end markets and adjacent technologies.
Request a free sample copy or view report summary: Medical Tubing Market Report
The global medical tubing industry is experiencing strong growth due to the rapid expansion of advanced healthcare technologies and the rising demand for high-performance tubing materials in medical devices
The growing adoption of medical metal tubing is another important factor driving market growth. Stainless steel and other medical-grade metal tubes are widely used in surgical instruments, hypodermic needles, guidewires, and catheter reinforcement because of their high strength, corrosion resistance, and precision tolerances.
Polyvinyl Chloride (PVC) accounted for the largest 30.5% revenue share in 2025 due to its cost-effectiveness, flexibility, and excellent compatibility with sterilization processes, making it widely used in IV tubing, blood bags, and fluid management systems
The bulk disposable tubing segment dominated the market in 2025 with a 34.1% revenue share due to its extensive use in single-use medical applications such as IV therapy, dialysis, blood transfusion, and fluid management systems.
The drug delivery systems segment is the fastest-growing segment due to the increasing adoption of advanced infusion systems, insulin pumps, and targeted drug delivery devices used for chronic disease management
North America accounted for the largest revenue share of 35.3% in 2025 due to the presence of a well-established healthcare infrastructure, strong medical device manufacturing base, and high adoption of advanced medical technologies
Grand View Research has segmented the global medical tubing market report based on product, application, and region:
Medical Tubing Product Outlook (Revenue, USD Million, 2021 - 2033)
Silicone
Polyolefins
Polyimide
Polyvinyl Chloride
Polycarbonates
Fluoropolymers
Polytetrafluoroethylene (PTFE)
Fluorinated ethylene propylene (FEP)
Others
Medical Tubing Application Outlook (Revenue, USD Million, 2021 - 2033)
Bulk disposable tubing
Silicone
Polyolefins
Polyimide
Polyvinyl Chloride
Polycarbonates
Fluoropolymers
Polytetrafluoroethylene (PTFE)
Fluorinated ethylene propylene (FEP)
Others
Drug delivery systems
Silicone
Polyolefins
Polyimide
Polyvinyl Chloride
Polycarbonates
Fluoropolymers
Polytetrafluoroethylene (PTFE)
Fluorinated ethylene propylene (FEP)
Others
Catheters
Silicone
Polyolefins
Polyimide
Polyvinyl Chloride
Polycarbonates
Fluoropolymers
Polytetrafluoroethylene (PTFE)
Fluorinated ethylene propylene (FEP)
Others
Biopharmaceutical laboratory equipment
Silicone
Polyolefins
Polyimide
Polyvinyl Chloride
Polycarbonates
Fluoropolymers
Polytetrafluoroethylene (PTFE)
Fluorinated ethylene propylene (FEP)
Others
Others
Silicone
Polyolefins
Polyimide
Polyvinyl Chloride
Polycarbonates
Fluoropolymers
Polytetrafluoroethylene (PTFE)
Fluorinated ethylene propylene (FEP)
Others
Medical Tubing Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Netherlands
Russia
Spain
UK
Asia Pacific
China
India
Japan
Australia
Singapore
South Korea
Latin America
Brazil
Middle East & Africa
South Africa
List of Key Players in Medical Tubing Market
Asahi Tec Corp.
MDC Industries
Nordson Corp.
ZARYS International Group
Hitachi Cable America Inc.
NewAge Industries, Inc.
TE Connectivity
Freudenberg & Co. KG
Spectrum Plastics Group
ATAG SpA
"The quality of research they have done for us has been excellent..."